Couling John D — SEC Form 4 filings

SEC reporting owner CIK 1894052. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-02-12 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dolby Laboratories, Inc. (DLB)SVP, Entertainment1520 legs · 287,920 sh · $21,857,75842

Form 4 filings — Couling John D

FiledFormIssuerReported transactionsSource
2026-09-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 48,076 @ $0EDGAR
2026-09-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 7,667 @ $61.05 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-08-054Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 783 @ $59.03 · Sale (S): 6,884 @ $60.11 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-07-064Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,667 @ $45.50 · Sale (S): 7,667 @ $53.20 · Option exercise (M): 7,667 (derivative) @ $0EDGAR
2026-06-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 7,666 @ $45.50 · Sale (S): 7,158 @ $55.59 · Sale (S): 508 @ $56.16 · Option exercise (M): 7,666 (derivative) @ $0EDGAR
2026-05-064Dolby Laboratories, Inc. (DLB)Sale (S): 4,688 @ $58.47 · Option exercise (M): 7,666 @ $45.50 · Sale (S): 6,928 @ $57.47 · Sale (S): 738 @ $58.34 · Option exercise (M): 7,666 (derivative) @ $0EDGAR
2026-02-044Dolby Laboratories, Inc. (DLB)Sale (S): 6,667 @ $64.89EDGAR
2025-12-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 25,633 @ $0 · Option exercise (M): 6,825 @ $0 · Tax withholding (F): 8,203 @ $67.54 · Tax withholding (F): 2,612 @ $66.62 · Grant/award (A): 12,816 (derivative) @ $0 · Grant/award (A): 56,440 (derivative) @ $0 · +1 moreEDGAR
2025-12-154Dolby Laboratories, Inc. (DLB)Sale (S): 7,273 @ $68.75EDGAR
2025-11-244Dolby Laboratories, Inc. (DLB)Sale (S): 6,164 @ $66.12EDGAR
2025-05-074Dolby Laboratories, Inc. (DLB)Sale (S): 675 @ $75.04EDGAR
2024-12-184Dolby Laboratories, Inc. (DLB)Grant/award (A): 20,733 @ $0 · Option exercise (M): 5,990 @ $0 · Tax withholding (F): 11,703 @ $79.18 · Grant/award (A): 10,366 (derivative) @ $0 · Grant/award (A): 36,446 (derivative) @ $0 · Option exercise (M): 5,990 (derivative) @ $0EDGAR
2024-11-264Dolby Laboratories, Inc. (DLB)Sale (S): 2,000 @ $81 · Option exercise (M): 40,000 @ $33.15 · Option exercise (M): 8,000 @ $64.60 · Sale (S): 48,000 @ $80 · Option exercise (M): 7,000 @ $64.60 · Sale (S): 7,000 @ $80.50 · +3 moreEDGAR
2024-02-124/ADolby Laboratories, Inc. (DLB)Option exercise (M): 50,000 @ $42.98 · Sale (S): 50,000 @ $80 · Option exercise (M): 12,440 @ $42.98 · Option exercise (M): 21,120 @ $62.32 · Sale (S): 33,560 @ $80.81 · Option exercise (M): 50,000 (derivative) @ $0 · +2 moreEDGAR
2024-02-124Dolby Laboratories, Inc. (DLB)Option exercise (M): 50,000 @ $42.98 · Sale (S): 50,000 @ $80 · Option exercise (M): 12,440 @ $42.98 · Option exercise (M): 21,120 @ $62.32 · Sale (S): 33,560 @ $80.81 · Option exercise (M): 50,000 (derivative) @ $0 · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1894052 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →